FI52081C - Menetelmä terapeuttisesti käyttökelpoisten 1-substituoitujen 1,3-dihyd ro-2H-1,4-bentsodiatsepiini-2-onien valmistamiseksi. - Google Patents
Menetelmä terapeuttisesti käyttökelpoisten 1-substituoitujen 1,3-dihyd ro-2H-1,4-bentsodiatsepiini-2-onien valmistamiseksi.Info
- Publication number
- FI52081C FI52081C FI710234A FI23471A FI52081C FI 52081 C FI52081 C FI 52081C FI 710234 A FI710234 A FI 710234A FI 23471 A FI23471 A FI 23471A FI 52081 C FI52081 C FI 52081C
- Authority
- FI
- Finland
- Prior art keywords
- benzodiazepin
- dihydro
- ones
- substituted
- preparation
- Prior art date
Links
- -1 1-substituted 1,3-dihydro-2H-1,4-benzodiazepin-2-ones Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
- C07D243/26—Preparation from compounds already containing the benzodiazepine skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
- C07D243/28—Preparation including building-up the benzodiazepine skeleton from compounds containing no hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
- C07D243/30—Preparation including building-up the benzodiazepine skeleton from compounds already containing hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
- C07D243/30—Preparation including building-up the benzodiazepine skeleton from compounds already containing hetero rings
- C07D243/36—Preparation including building-up the benzodiazepine skeleton from compounds already containing hetero rings containing an indole or hydrogenated indole ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP969170A JPS4910954B1 (OSRAM) | 1970-02-03 | 1970-02-03 | |
| JP1053370A JPS4834600B1 (OSRAM) | 1970-02-05 | 1970-02-05 | |
| JP5552970A JPS4831118B1 (OSRAM) | 1970-06-24 | 1970-06-24 | |
| JP5553070A JPS4831119B1 (OSRAM) | 1970-06-24 | 1970-06-24 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI52081B FI52081B (OSRAM) | 1977-02-28 |
| FI52081C true FI52081C (fi) | 1977-06-10 |
Family
ID=27455232
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI710234A FI52081C (fi) | 1970-02-03 | 1971-01-28 | Menetelmä terapeuttisesti käyttökelpoisten 1-substituoitujen 1,3-dihyd ro-2H-1,4-bentsodiatsepiini-2-onien valmistamiseksi. |
Country Status (13)
| Country | Link |
|---|---|
| BE (1) | BE762404A (OSRAM) |
| CA (1) | CA970368A (OSRAM) |
| CH (3) | CH549033A (OSRAM) |
| DE (1) | DE2166473A1 (OSRAM) |
| DK (1) | DK134018B (OSRAM) |
| FI (1) | FI52081C (OSRAM) |
| FR (1) | FR2081482B1 (OSRAM) |
| GB (1) | GB1309948A (OSRAM) |
| IL (1) | IL36121A (OSRAM) |
| NL (1) | NL169072C (OSRAM) |
| NO (1) | NO131031C (OSRAM) |
| PL (1) | PL70900B1 (OSRAM) |
| SE (1) | SE364714B (OSRAM) |
-
1971
- 1971-01-06 CH CH1648473A patent/CH549033A/xx not_active IP Right Cessation
- 1971-01-27 DK DK35571AA patent/DK134018B/da not_active IP Right Cessation
- 1971-01-28 FI FI710234A patent/FI52081C/fi active
- 1971-01-28 NO NO300/71A patent/NO131031C/no unknown
- 1971-01-29 FR FR7103060A patent/FR2081482B1/fr not_active Expired
- 1971-02-01 DE DE19712166473 patent/DE2166473A1/de active Pending
- 1971-02-01 CH CH144371A patent/CH578543A5/xx not_active IP Right Cessation
- 1971-02-01 CH CH1089574A patent/CH581632A5/xx not_active IP Right Cessation
- 1971-02-02 PL PL1971145964A patent/PL70900B1/pl unknown
- 1971-02-02 NL NLAANVRAGE7101382,A patent/NL169072C/xx not_active IP Right Cessation
- 1971-02-02 BE BE762404A patent/BE762404A/xx not_active IP Right Cessation
- 1971-02-02 IL IL36121A patent/IL36121A/xx unknown
- 1971-02-02 SE SE01297/71A patent/SE364714B/xx unknown
- 1971-02-02 CA CA104,284A patent/CA970368A/en not_active Expired
- 1971-04-19 GB GB2082771A patent/GB1309948A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FI52081B (OSRAM) | 1977-02-28 |
| CA970368A (en) | 1975-07-01 |
| DE2104571B2 (de) | 1976-03-04 |
| PL70900B1 (en) | 1974-04-30 |
| NO131031B (OSRAM) | 1974-12-16 |
| NL7101382A (OSRAM) | 1971-08-05 |
| FR2081482B1 (OSRAM) | 1975-10-10 |
| DK134018C (OSRAM) | 1977-01-31 |
| NO131031C (OSRAM) | 1975-03-25 |
| CH581632A5 (OSRAM) | 1976-11-15 |
| NL169072C (nl) | 1982-06-01 |
| CH549033A (de) | 1974-05-15 |
| SE364714B (OSRAM) | 1974-03-04 |
| DE2104571A1 (de) | 1971-08-05 |
| FR2081482A1 (OSRAM) | 1971-12-03 |
| NL169072B (nl) | 1982-01-04 |
| IL36121A (en) | 1975-08-31 |
| CH578543A5 (OSRAM) | 1976-08-13 |
| DK134018B (da) | 1976-08-30 |
| BE762404A (fr) | 1971-07-16 |
| GB1309948A (en) | 1973-03-14 |
| IL36121A0 (en) | 1971-04-28 |
| DE2166473A1 (de) | 1974-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI49034C (fi) | Menetelmä terapeuttisesti vaikuttavan 3,4-dihydroisokinoliinijohdannai sen valmistamiseksi. | |
| FI49517C (fi) | Menetelmä terapeuttisesti arvokkaan 2'beta-isopropyyli-5'alfa-n-propyy li-9,10-dihydro-ergopeptiinin valmistamiseksi. | |
| FI49965C (fi) | Menetelmä terapeuttisesti käytettävien 1,3-dihydro-1-(metoksimetyyli)- 5-fenyyli-2H-1,4-bentsodiatsepiini-2-onien valmistamiseksi. | |
| ZA712368B (en) | 5,7-disubstituted-1,9-alkylene-1,4-benzodiazepin-2-ones | |
| DK137754B (da) | Fremgangsmåde til fremstilling af 1,4-benzodiazepinderivater. | |
| NL162691C (nl) | Werkwijze voor de bereiding van 1,6-alfa-glucosidasen. | |
| FI51349C (fi) | Menetelmä terapeuttisesti vaikuttavien N-substituoitujen 6,7-bentsomor faanien valmistamiseksi. | |
| FI52084C (fi) | Menetelmä 5-fenyyli-1,3-dihydro-2H-1,4-bentsodiatsepin-2-onien valmist amiseksi. | |
| FI52581C (fi) | Menetelmä terapeuttisesti käytettävien N-(1,1-ditienyyli-propyyli-(3)) -fenyylietyyliamiinien valmistamiseksi. | |
| FI50978C (fi) | Menetelmä 1-hydroksialkyyli-5-fenyyli-1,3-dihydro-2H-1,4-bentsodiatsep iini-2-onijohdannaisten valmistamiseksi. | |
| NL160258B (nl) | Werkwijze voor de bereiding van 2,3-dihydrobenzodia- zepinen. | |
| SU418225A1 (OSRAM) | ||
| NL155544B (nl) | Werkwijze voor de bereiding van 5-fenyl-2,3-dihydro-1,4-benzodiazepinen. | |
| FI52721C (fi) | Uusi menetelmä 1-substituoitujen 5-fenyyli-2,3-dihydro-1H-1,4-bentsodi atsepiinijohdannaisten valmistamiseksi | |
| FI52082C (fi) | Menetelmä uusien terapeuttisesti vaikuttavien 1,4-bentsodiatsepin-2-on ien valmistamiseksi | |
| FI51483C (fi) | Menetelmä terapeuttisesti aktiivisten 1,4-bentsodiatsepiini-2-onien va lmistamiseksi | |
| AU451389B2 (en) | "3h-1,4-benzodiazepines" | |
| DK137855B (da) | Analogifremgangsmåde til fremstilling af optisk aktive 1,3,4,5-tetrahydro-2H-1,4-benzodiazepin-2-on-derivater. | |
| FI52083C (fi) | Tapa valmistaa 7-nitro-5-fenyyli-1,3-dihydro-2H-1,4-bentsodiatsepiini- 2-onia | |
| FI49040C (fi) | Menetelmä 2,3-dihydro-1H-1,4-bentsodiatsepiinien valmistamiseksi. | |
| AR195591A1 (es) | Procedimiento para la preparacion de compuestos de 1,4-benzodiazepina 1-sustituidos | |
| FI49966C (fi) | Uusi menetelmä 1,4-bentsodiatsepiini-2-onien valmistamiseksi. | |
| CA854193A (en) | Process for the manufacture of 2,4-benzodiazepines | |
| CA770615A (en) | Process for the manufacture of 1-substituted 1,3-dihydro-2h-1,4-benzodiazepin-2-one compounds | |
| FI50626C (fi) | 2,3-dihydro-5-fenyyli-1H-1,4-bentsodiatsepiinien valmistusmenetelmä. |